Jose Manuel Otero
COO at Lexeo Therapeutics, Inc. (LXEO); Chief Technical Officer at Lexeo Therapeutics, Inc. (LXEO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $86K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 19SEC | LXEOLexeo Therapeutics, Inc. | Sell | 1,304136,178 held (−1%) | $4.96 | $6K | -34.9% |
| Jul 1SEC | LXEOLexeo Therapeutics, Inc. | Sell | 4,666137,482 held (−3%) | $4.48 | $21K | -27.9% |
| May 20SEC | LXEOLexeo Therapeutics, Inc. | Sell | 1,302130,088 held (−1%) | $5.07 | $7K | -36.3% |
| Feb 20SEC | LXEOLexeo Therapeutics, Inc. | Sell | 72163,476 held (−1%) | $9.27 | $7K | -65.2% |
| Feb 20SEC | LXEOLexeo Therapeutics, Inc. | Sell | 3,016125,460 held (−2%) | $6.40 | $19K | -49.5% |
| Nov 20SEC | LXEOLexeo Therapeutics, Inc. | Sell | 72163,476 held (−1%) | $9.27 | $7K | -65.2% |
| Oct 17SEC | LXEOLexeo Therapeutics, Inc. | Sell | 2,09164,221 held (−3%) | $8.94 | $19K | -63.9% |
| Oct 17SEC | LXEOLexeo Therapeutics, Inc. | Sell | 2464,197 held (−0%) | $9.56 | $229 | -66.2% |